Evicenter
MarkdownMedical informationP&T meetings
Claseprubart (DNTH103)

Generalized myasthenia gravis

Launch
Not announced
Last updated
120 sources

Product information and disease descriptionProduct description

Product information

76 evidence topics · 34 sources

Average sales price and wholesale acquisition cost

Not applicable.

Effect of Claseprubart on quality measures

No evidence found.